Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: J Immunol. 2008 Nov 15;181(10):6913–6922. doi: 10.4049/jimmunol.181.10.6913

Table 1.

Lymphocyte subpopulations in heterozygous and homozygous DN transgenics.

CON (7–9wks) TG D+/− (7–9 wks) CON (10–13 wks) TG D+/+ (10–13wks)
Bone Marrow Cells (per femur)
 Total (×107) 2.10 ± 0.34(8) 2.05 ± 0.31(9) 1.96 ± 0.22(13) 1.79 ± 0.13(9)
 B220+ (×106) 1.7 ± 0.3 2.2 ± 0.2 2.8 ± 0.4 2.4 ± 0.3
 Pro B (×105) 4.7 ± 0.8 5.3 ± 0.6 4.4 ± 0.4 4.4 ± 0.7
 Pre B (×105) 8.8 ± 2.0 11.6 ± 1.9 10.3 ± 2.0 8.9 ± 1.7
 Immature (×105) 3.1 ± 0.9 3.4 ± 0.6 3.8 ± 0.7 3.3 ± 0.6
 Recirculating (×105) 8.0 ± 2.2 6.1 ± 1.3 6.7 ± 1.0 5.4 ± 1.2
Spleen Cells
 Total (×107) 19.7 ± 1.9(6) 13.6 ± 1.2(9) 15.7 ± 1.2(11) 13.6 ± 1.5(11)
 T1 (×106) 3.8 ± 0.6 3.4 ± 0.5 6.0 ± 1.3 7.5 ± 1.7
 T2 (×106) 5.2 ± 1.0 4.0 ± 0.3 9.2 ± 1.6 7.8 ± 1.4
 T3 (×106) 3.5 ± 0.9 1.9 ± 0.4 3.5 ± 0.6 3.0 ± 0.5
 MZ (×106) 11.5 ± 1.4 7.8 ± 1.1* 6.6 ± 0.5 7.0 ± 0.6
 Follicular (×106) 39.5 ± 4.4 28.0 ± 3.2** 33.1 ± 3.7 32.0 ± 3.6

Male or female mice of ages indicated were analyzed. Numbers represent the mean ± SEM. Sample size is shown in parentheses after average total cell number for each tissue. Student’s T test,

*

p = 0.0325;

**

p = 0.0285.